Cardiac Transplantation and New Frontiers in Hypertrophic Cardiomyopathy

Presenters: Ahmet Kilic, MD; Anjali Tiku Owens, MD, Ferhaan Ahmad, MD, PhD, FRCPC, FAHA, FACC, Ovuke' Emonina McCoy

Summary: Surgical and interventional options such as surgical myectomy or alcohol septal ablation may help those with obstructive HCM to reduce or remove the obstruction. A similar option is unavailable to those with non-obstructive HCM. Heart transplants are considered as a last resort for HCM patients who progress to end stages of the disease. Learn more about advanced surgical approaches and emerging medical therapies for HCM.

Ferhaan Ahmad MD PhD

Ferhaan Ahmad, MD, PhD
Associate Professor of Internal Medicine, Radiology, and Molecular Physiology and Biophysics
Director, Cardiovascular Genetics Program
Director, Cardiovascular Disease Fellowship Program
Division of Cardiovascular Medicine, Department of Internal Medicine, University of Iowa Carver College of Medicine

Ahmet Kilic

Ahmet Kilic, MD, FACS
Director, Heart Transplantation
Program Director, Cardiothoracic Surgery
Associate Professor, Division of Cardiac Surgery
The Johns Hopkins Hospital

Anjali Owens MD

Anjali Tiku Owens, MD
Assistant Professor of Medicine
University of Pennsylvania

Ovuke' Emonina McCoy

Ovuke' Emonina McCoy
Patient Representative